pargyline has been researched along with Ptosis, Eyelid in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuentes, JA | 1 |
| Neff, NH | 1 |
| Huebner, CF | 1 |
| Donoghue, EM | 1 |
| Plummer, AJ | 1 |
| Furness, PA | 1 |
2 other studies available for pargyline and Ptosis, Eyelid
| Article | Year |
|---|---|
Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.
Topics: Animals; Blepharoptosis; Body Temperature; Clorgyline; Cyclopropanes; Harmaline; In Vitro Techniques | 1975 |
N-methyl-n-2-propynyl-l-indanamine. A protent monoamine oxidase inhibitor.
Topics: Animals; Behavior, Animal; Blepharoptosis; Chemistry, Organic; Drug Antagonism; Indenes; Mice; Monoa | 1966 |